Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
February 19, 2020

Audentes Therapeutics to build gene therapy manufacturing facility in North Carolina

Astellas company Audentes Therapeutics has unveiled plans to construct a new gene therapy manufacturing facility in Sanford, North Carolina, US.

Continue
Architectural rendering of Audentes Therapeutics new gene therapy manufacturing facility planned in Sanford, North Carolina (Credit: Business Wire)
February 19, 2020

Pfizer’s VYNDAQEL gets EC approval for treatment of ATTR-CM

EC approves Pfizer’s VYNDAQEL for transthyretin amyloid cardiomyopathy. (Credit: Coolcaesar/Wikipedia.org)
February 18, 2020

Novartis gets EC nod for Beovu to treat wet AMD

Image: Novartis has secured EC approval for Beovu to treat wet AMD. Photo: courtesy of Novartis AG.

Contracts

November 22, 2019

ViiV Healthcare, NIH collaborate on investigational bNAb for HIV treatment

Image: ViiV Healthcare to develop investigational bNAbs. Photo: Courtesy of GlaxoSmithKline plc.

WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract

TaiwanJ Pharmaceuticals out-licenses liver drug candidate in Asia

GeoVax, Leidos expand collaboration to malaria vaccines

Deals

Deals February 12, 2020

Dr. Reddy’s Laboratories to acquire select business divisions of Wockhardt in India

Pharmaceutical Business Review

Ligand agrees to acquire core assets, partnered programmes and ion channel technologies from Icagen

Valeritas announces agreement for Zealand Pharma to acquire business and retain employees

Apollo to buy speciality pharmaceutical company Covis Pharma

Popular

  1. Gilead, Renown Institute for Health Innovation announce collaboration to advance understanding of NASH
  2. Celsius Therapeutics signs collaboration agreement with Janssen to identify response biomarkers for ulcerative colitis
  3. Ipsen, Servier announce initial phase 1/2 data of liposomal irinotecan in metastatic pancreatic cancer
  4. VALBIOTIS announces positive results from phase IIA trial of VALEDIA in prediabetics
  5. GSK begins phase 3 trial for otilimab in patients with rheumatoid arthritis

PRESS RELEASES

Pharmaceutical Business Review
Denny Bros’ Green Credentials Underlined by 2019 Statistics
Pharmaceutical Business Review
Actide to Attend 5th European Conference for Clinical Research
SGS 2019 Full Year Results
SGS 2019 Full Year Results
Upcoming Pharma Courses
Upcoming Pharma Courses
Innovative Fix-a-Form labels
Innovative Fix-a-Form labels

Suppliers

Whitepapers

Registration of pharmaceutical products and substances
Registration of pharmaceutical products and substances
Trademark and intellectual property registration services
Trademark and intellectual property registration services
Improving Security in the Pharmaceutical Industry
Improving Security in the Pharmaceutical Industry